Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Stock
Equities
6990
CNE1000062J1
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 434.80 HKD | -3.89% |
|
-5.40% | +10.86% |
| Capitalization | 87.83B 101B 12.95B 11.09B 10.14B 9.66B 17.77B 1,240B 17.93B 121B 47.03B 590B 48.58B 47.54B 2,050B | P/E ratio 2026 * |
-438x | P/E ratio 2027 * | 140x |
|---|---|---|---|---|---|
| Enterprise value | 84.65B 97.71B 12.48B 10.69B 9.77B 9.31B 17.12B 1,195B 17.28B 117B 45.32B 569B 46.82B 45.82B 1,976B | EV / Sales 2026 * |
31.4x | EV / Sales 2027 * | 18.7x |
| Free-Float |
53.3% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
| 1 day | -3.89% | ||
| 1 week | -5.40% | ||
| Current month | -7.37% | ||
| 1 month | -10.76% | ||
| 3 months | +3.87% | ||
| 6 months | -4.40% | ||
| Current year | +10.86% |
| 1 week | 428.2 |  | 470 |
| 1 month | 428.2 | | 529.5 |
| Current year | 339.6 | | 529.5 |
| 1 year | 296.2 | | 581 |
| 3 years | 60.6 | | 581 |
| 5 years | 60.6 | | 581 |
| 10 years | 60.6 | | 581 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jun You Ge
CEO | Chief Executive Officer | 54 | 2022-02-28 |
Ze Jian Zhou
DFI | Director of Finance/CFO | 43 | 2022-08-16 |
Xiao Ping Jin
CTO | Chief Tech/Sci/R&D Officer | 49 | 2021-09-05 |
| Director | Title | Age | Since |
|---|---|---|---|
Ge Xin Liu
CHM | Chairman | 75 | 2022-02-28 |
Jun You Ge
BRD | Director/Board Member | 54 | 2022-02-24 |
Si Chuan Liu
BRD | Director/Board Member | 42 | 2016-11-21 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.89% | -5.40% | +38.03% | - | 13.47B | |
| +1.02% | +0.84% | +42.05% | +87.52% | 50.04B | |
| -5.43% | -5.50% | +72.08% | +55.56% | 48.62B | |
| -2.01% | -15.66% | +75.95% | +517.30% | 25.57B | |
| -0.26% | -3.43% | -2.66% | -12.59% | 23.32B | |
| -3.60% | -1.03% | +40.99% | -29.12% | 17.89B | |
| -1.66% | -4.83% | +32.60% | -41.30% | 16.2B | |
| -2.75% | -7.27% | +53.03% | +190.95% | 14.97B | |
| -3.46% | +1.62% | -26.29% | +954.65% | 14.58B | |
| -0.37% | +4.93% | +38.29% | +166.42% | 12.89B | |
| Average | -2.24% | -1.86% | +36.41% | +209.93% | 23.76B | |
| Weighted average by Cap. | -2.15% | -2.47% | +42.80% | +168.47% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.7B 3.12B 398M 341M 312M 297M 546M 38.1B 551M 3.72B 1.45B 18.14B 1.49B 1.46B 63B | 4.5B 5.19B 663M 568M 519M 495M 910M 63.5B 918M 6.2B 2.41B 30.24B 2.49B 2.44B 105B |
| Net income | -204M -236M -30.12M -25.81M -23.59M -22.46M -41.33M -2.88B -41.71M -282M -109M -1.37B -113M -111M -4.77B | 633M 730M 93.23M 79.89M 73.03M 69.54M 128M 8.93B 129M 872M 339M 4.25B 350M 342M 14.76B |
| Net Debt | -3.18B -3.68B -469M -402M -368M -350M -644M -44.94B -650M -4.39B -1.7B -21.4B -1.76B -1.72B -74.31B | -3.75B -4.33B -553M -474M -433M -413M -759M -52.99B -766M -5.18B -2.01B -25.23B -2.08B -2.03B -87.62B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-05-14 | 434.80 $ | -3.89% | 673,235 |
| 26-05-13 | 452.40 $ | -1.82% | 652,201 |
| 26-05-12 | 460.80 $ | +2.58% | 547,427 |
| 26-05-11 | 449.20 $ | +0.45% | 636,499 |
| 26-05-08 | 447.20 $ | -1.71% | 459,899 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 6990 Stock
Select your edition
All financial news and data tailored to specific country editions
